- Email: [email protected]
EUFEPS Conference on Optimising Biotech Medicines: Second-Generation Pharmaceuticals
european journal of pharmaceutical sciences 28 (2006) 442
available at www.sciencedirect.com
j o u r n a l h o m e p a g e : w w w . e l s e v i e r. c o m / l o c a t e / e j p s
EUFEPS Conference on Optimising Biotech Medicines: Second-Generation Pharmaceuticals January • 2007 • Munich • Germany Scope and Aim Today, a major fraction of NDA’s includes biologicals, i.e. biotech medicines. Part of those is second-generation biologicals. The biologicals differ from low molecular weight drugs because of their complex production and purification process and a different quality control paradigm, including different analytical and formulation approaches. In this conference the following issues will be addressed: • Production processes for biologicals: optimisation of protein excretion and downstream processing protocols • Second generation biologicals: design and manufacture (e.g. epo-derivatives and pegylation approaches) • Formulation of biologicals: route of administration, characterisation and stability Ample meeting time will be devoted to round-table discussions and break out sessions in addition to the invited state-of-the-art lectures. Who should attend? This conference is meant to bring together leading experts in the field of biotech medicines. The interactive nature makes it an excellent platform for both experts and scientists relatively new to the field to discuss the different challenges encountered when working with biotech medicines and possible solutions in a multidisciplinary setting. Scientific & Planning Committee Daan J.A. Crommelin, Leiden, NL (Chair); Theo Dingermann, Frankfurt, DE; Wolfgang Friess, Munich, DE; Ulrike Holzgrabe, Würzburg, DE; Christian R. Noe, Vienna, AT; Hans H. Linden, Stockholm, SE; Angelica M. Vollmar, Munich, DE; Ernst Wagner, Munich, DE; Gerhard Winter, Munich, DE. Posters and Exhibition Scientific contributions relating to the scope and aim of the Conference will be welcome and considered for poster presentations. Companies are welcome to participate as exhibitor at this Conference. Additional information For more information, see circulating announcements, consult the EUFEPS Online (www.eufeps.org) or contact the EUFEPS Secretariat. EUFEPS Secretariat, PO Box 1136, SE-111 81 Stockholm, Sweden, Fax: +46 8 4113217, Tel.: +46 8 7235000, Email: [email protected], Website: www.eufeps.org
doi:10.1016/S0928-0987(06)00187-4
available at www.sciencedirect.com
j o u r n a l h o m e p a g e : w w w . e l s e v i e r. c o m / l o c a t e / e j p s
EUFEPS Conference on Optimising Biotech Medicines: Second-Generation Pharmaceuticals January • 2007 • Munich • Germany Scope and Aim Today, a major fraction of NDA’s includes biologicals, i.e. biotech medicines. Part of those is second-generation biologicals. The biologicals differ from low molecular weight drugs because of their complex production and purification process and a different quality control paradigm, including different analytical and formulation approaches. In this conference the following issues will be addressed: • Production processes for biologicals: optimisation of protein excretion and downstream processing protocols • Second generation biologicals: design and manufacture (e.g. epo-derivatives and pegylation approaches) • Formulation of biologicals: route of administration, characterisation and stability Ample meeting time will be devoted to round-table discussions and break out sessions in addition to the invited state-of-the-art lectures. Who should attend? This conference is meant to bring together leading experts in the field of biotech medicines. The interactive nature makes it an excellent platform for both experts and scientists relatively new to the field to discuss the different challenges encountered when working with biotech medicines and possible solutions in a multidisciplinary setting. Scientific & Planning Committee Daan J.A. Crommelin, Leiden, NL (Chair); Theo Dingermann, Frankfurt, DE; Wolfgang Friess, Munich, DE; Ulrike Holzgrabe, Würzburg, DE; Christian R. Noe, Vienna, AT; Hans H. Linden, Stockholm, SE; Angelica M. Vollmar, Munich, DE; Ernst Wagner, Munich, DE; Gerhard Winter, Munich, DE. Posters and Exhibition Scientific contributions relating to the scope and aim of the Conference will be welcome and considered for poster presentations. Companies are welcome to participate as exhibitor at this Conference. Additional information For more information, see circulating announcements, consult the EUFEPS Online (www.eufeps.org) or contact the EUFEPS Secretariat. EUFEPS Secretariat, PO Box 1136, SE-111 81 Stockholm, Sweden, Fax: +46 8 4113217, Tel.: +46 8 7235000, Email: [email protected], Website: www.eufeps.org
doi:10.1016/S0928-0987(06)00187-4